Global insurance float machine — $745B balance sheet, $5.9B adjusted earnings, six segments

• Group Benefits ($1.7B adj. earnings). Largest U.S. group insurer — serves 80% of the Fortune 500, 3× bigger than its closest rival. Sticky employer relationships.
• RIS + Asia ($3.4B combined). Record $14.2B pension risk transfer in FY25 plus Japan-led Asia life block generate spread income on a $450B+ invested portfolio.
• MIM ($735B AUM). December 2025 PineBridge deal made it a top-25 institutional asset manager — capital-light fee income targeting $1T AUM by 2029.

Adjusted earnings hit record $5.9B — but GAAP noise keeps the market confused

OCF has grown every year since 2020 while GAAP EPS gyrated from $9.13 to $2.07 and back. Buybacks shrank float 29% in six years — built-in 6% EPS tailwind at current pace.

B+ governance — deep bench and clean pay, but zero insider buying at the lows

• Leadership. CEO Michel Khalaf (since 2019) holds $39M in stock, well above the 7× salary requirement. FY24 comp $20.3M, 93% variable.
• Board. 10 of 11 directors independent; Chair Glenn Hubbard separate from CEO. Four new directors in three years, including ex-Swiss Re CEO Mumenthaler.
• Capital return. $3.9B buybacks plus $1.7B dividends in FY25 — $5.6B total, 31% of OCF. Dividend raised 4.1% to $0.5675/quarter.
• Insider activity. Zero open-market buys by any executive or director in the trailing year despite stock near 52-week lows — a conviction gap.

From SIFI-era conglomerate to focused insurance franchise — now pivoting to asset management

2015–2020: Simplification. MetLife fought and won its SIFI designation in court (2016), spun off Brighthouse Financial (2017), and sold home & auto to Farmers for $3.94B (2021). CEO Khalaf launched “Next Horizon” in 2019 — focus, simplify, differentiate. The company delivered its expense ratio target (12.4% vs 12.6% promised) and exited its most volatile businesses.

2024–2026: New Frontier. December 2024 Investor Day pivoted to offense: double-digit EPS growth, 15–17% adjusted ROE, $1T AUM by 2029. PineBridge closed for $1.2B in Dec 2025, pushing MIM AUM to $741.7B. Talcott $10B reinsurance deal de-risked legacy Holdings block. MIM adjusted earnings jumped from $55M to $200M in one year — the capital-light pivot is real but unproven.

Preliminary Q1 VII disclosure sets up a beat — but MET has trailed the S&P by 27 points

• Q1 VII tailwind. April 7 8-K disclosed $475–525M pre-tax variable investment income for Q1 2026 — well above the ~$400M run-rate. Full Q1 earnings May 6 (consensus $2.21 EPS).
• Analyst dispersion. 19 analysts, average target $91.44 (+23% upside). UBS raised to $102, Evercore to $96; Barclays cut to $89 and Wells Fargo to $90 — all still Buy/Overweight.
• Underperformance gap. MET up 8.7% over 52 weeks vs S&P +36.1% and XLF +16.6%. Hit 52-week low $67.33 on Mar 27 before bouncing to $73.88.

Three risks that could each reprice the stock 10–20%

• Rate-cut spread compression. A 200bp Fed cut within 12 months would narrow investment spreads despite hedges. Management models a 50bp cut as a $38M–$138M annual earnings hit — larger moves scale non-linearly.
• Long-term care tail. LTC reserves sit quietly in Corporate & Other with crediting rates that can’t be lowered. A $500M+ reserve charge would resurface legacy tail risk buried since the Brighthouse spin.
• GAAP opacity overhang. Reported EPS of $4.71 understates adjusted EPS of $8.89 by nearly 50%. If the market refuses to look through LDTI and MRB noise, the 7.5× multiple may prove permanent.